Cargando…
Decelerated DNA methylation age predicts poor prognosis of breast cancer
BACKGROUND: DNA methylation (DNAm) age was found to be an indicator for all-cause mortality, cancer incidence, and longevity, but no study has involved in the associations of DNAm age with the prognosis of breast cancer. METHODS: We retrieved information of 1076 breast cancer patients from Genomic D...
Autores principales: | Ren, Jun-Ting, Wang, Mei-Xia, Su, Yi, Tang, Lu-Ying, Ren, Ze-Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6191915/ https://www.ncbi.nlm.nih.gov/pubmed/30333003 http://dx.doi.org/10.1186/s12885-018-4884-6 |
Ejemplares similares
-
Molecular features in young vs elderly breast cancer patients and the impacts on survival disparities by age at diagnosis
por: Wang, Mei‐Xia, et al.
Publicado: (2018) -
High DNA methylation age deceleration defines an aggressive phenotype with immunoexclusion environments in endometrial carcinoma
por: Hao, Jing, et al.
Publicado: (2023) -
Circulating Methylated XAF1 DNA Indicates Poor Prognosis for Gastric Cancer
por: Ling, Zhi-Qiang, et al.
Publicado: (2013) -
DNA Methylation Based Molecular Subtypes Predict Prognosis in Breast Cancer Patients
por: Wu, Zeng-Hong, et al.
Publicado: (2021) -
Methylated DNA and high total DNA levels in the serum of patients with breast cancer following neoadjuvant chemotherapy are predictive of a poor prognosis
por: FUJITA, NORIKO, et al.
Publicado: (2014)